The A2 Milk Company Ltd (ASX: A2M) share price is in focus today after it received final regulatory approval in China for its infant milk formula products, with the board proposing a special $300 million dividend.
Image source: Getty Images
What did The a2 Milk Company report?
- Received State Administration for Market Regulation (SAMR) approval in China for two infant milk formula (IMF) product registrations
- Regulatory step completes the transition of a2 Pokeno facility registrations to a2™ branded products
- Launch of new China label IMF products expected later in 2026
- Board intends to declare a fully franked and unimputed $300 million special dividend
What else do investors need to know?
With the SAMR approval secured, a2MC cannot unwind its acquisition of the a2 Pokeno manufacturing facility. This step finalises the regulatory requirements set out during the initial purchase, allowing the company to move forward with product launches as originally planned.
The a2 Milk Company has confirmed there is no change to either the timing of new product launches or its previously stated financial forecasts as a result of this approval. Details regarding the timing and payment of the special dividend will be shared in a separate announcement once approved by the board.
What did The a2 Milk Company management say?
Managing Director and CEO David Bortolussi said:
SAMR approval marks a significant milestone in our China growth strategy and Supply Chain transformation. It supports long-term growth in our core IMF business through market access and innovation, accelerates the development of advanced nutritional manufacturing capability, and captures attractive financial returns through incremental brand contribution and vertical margin capture.
What's next for The a2 Milk Company?
The company expects to launch its newly approved China label IMF products later in the 2026 calendar year, delivering on its growth and innovation plans for the key Chinese market. Management remains committed to delivering the previously outlined financial and strategic benefits from the acquisition and product transition.
Shareholders can expect more information soon about the timing and payment of the proposed $300 million fully franked special dividend, pending formal board approval.
The a2 Milk Company share price snapshot
Over the past 12 months, a2 Milk Company shares have declined 17%, trailing the S&P/ASX 200 Index (ASX: XJO) which has risen 4% over the same period.
